Your shopping cart is currently empty

VPM-p15 is an optimized peptide agonist targeting the adhesion G protein-coupled receptor GPR64 (also known as ADGRG2 or HE6). It exhibits significantly higher affinity for GPR64 compared to the original p15 peptide. VPM-p15 significantly elevates cAMP levels, activating GPR64 and triggering downstream Gs, Gq, and G12/13 signaling pathways. This compound can be utilized in research focused on activation mechanisms of adhesion GPCR family members.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | VPM-p15 is an optimized peptide agonist targeting the adhesion G protein-coupled receptor GPR64 (also known as ADGRG2 or HE6). It exhibits significantly higher affinity for GPR64 compared to the original p15 peptide. VPM-p15 significantly elevates cAMP levels, activating GPR64 and triggering downstream Gs, Gq, and G12/13 signaling pathways. This compound can be utilized in research focused on activation mechanisms of adhesion GPCR family members. |
| Formula | C75H126N18O22 |
| Sequence | Val-Ser-{Phe(4-Me)}-Gly-Ile-Leu-Leu-Asp-Leu-Ser-Arg-Thr-Ser-Leu-Pro |
| Sequence Short | VS-{Phe(4-Me)}-GILLDLSRTSLP |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.